GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Dana-Farber Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
Tr1X, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SCRI Development Innovations, LLC
Melbourne Health
University of Kansas Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
M.D. Anderson Cancer Center
IRCCS San Raffaele
Baylor College of Medicine
University College, London
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Dana-Farber Cancer Institute
Eisai Inc.
University of Chicago
Northwestern University
Northwestern University
Dana-Farber Cancer Institute
Healios K.K.
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)